About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
State of the Art and Next Questions: T-Cell Lymphoma
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Matthew Lunning
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Matthew Lunning
23 views
March 29, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
23:03
MyCancerHaven
Basics of T-Cell Lymphoma: Diagnosis and Treatment
Feat.
R. Vij,
N. Mehta-Shah
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium
T-Cell Lymphomas: Impact of Classification on Treatment
Feat.
N. Mehta-Shah
21:53
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
Therapeutic Advances in T-Cell Lymphomas
Feat.
S. Barta
11:01
i3 Health
Diagnosis and Evidence-Based Management of T-Cell Lymphoma
Feat.
A. Goodman
34:28
Indy Hematology Review
Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas
Feat.
T. Phillips
10:50
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: T-Cell Lymphoma
Feat.
M. Lunning
18:10
SOHO Brazil 2023
2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Feat…
Feat.
A. Moskowitz
19:32
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Tailoring Therapy for PTCL
Feat.
J. Zain
16:27
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Therapeutic Advances in T-Cell Lymphoma in 2024
Feat.
S. Barta
18:39
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Managing Rare T-Cell Lymphoma Subtypes
Feat.
B. Pro
12:55
Yale Cancer Center
ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma
Feat.
T. Sethi
18:54
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: New Insights Into the Pathogenesis of T-Cell Lymphoma and…
Feat.
L. de Leval
26:12
Indy Hematology Review
What We Recommend for Aggressive B- and T-Cell Lymphomas in 2022
Feat.
J. Leonard
27:47
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…
Feat.
S. Smith
29:34
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights - State of the Art & Next Questions: T-Cell Lymp…
Feat.
B. Pro
10:55
PrecisCa
Heme Tumor Board: 60 y/o Female Presents With Newly Diagnosed CD30- …
Feat.
D. Pollyea,
T. Fraum,
M. Thirman,
M. Kamdar
27:51
Indy Hematology Review
Standard Management of Aggressive Lymphomas and Data on Emerging The…
Feat.
J. Leonard
03:10
PrecisCa
What Is Hepatosplenic T-Cell Lymphoma and How Do You Treat It?
Feat.
J. Abramson
23:26
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Harnessing the Immune System in Patients With Lymphoma
Feat.
S. Ansell
30:40
[PRIVATE] 2022 AAD Annual Meeting Coverage
Melanoma: New Therapies in Advanced Stage III and Stage IV
Feat.
B. Dreno